A survey report by market research and data analytics firm, YouGov, has indicated that while there is a demand for home pharmacy delivery among consumers,
the current supply or awareness of this type of service appears to be low.
The poll found that approximately one-fifth of British consumers (18 per cent) have used a pharmacy delivery service in the past year.
However, more than double that figure (40 per cent) expressed their intent to use such a service in the next 12 months if it were available, suggesting an
opportunity for growth in this sector.
This difference is especially pronounced in the Midlands, Scotland, and Wales, where the potential demand more than triples actual use.
Compared to other regions, the current use of pharmacy delivery services is notably low in the Midlands, standing at 12 per cent, and in Wales and Scotland,
where the collective usage rate stands at 14 per cent.
A recent survey conducted by the British Society Attitudes (BSA) and published by the King's Fund and the Nuffield Trust highlighted people's satisfaction
with the National Health Services (NHS) to be a new record low since the survey's inception in 1983.
The latest findings that are based on the public satisfaction and opinion with the NHS and social care, and funding in the context of prominent national debate
about taxation and healthcare spending reveal the satisfaction with the NHS to have dwindled across all services and demographics in 2023.
Public contentment has sharply declined, with only 24 per cent expressing satisfaction in 2023, a significant drop from 2020.
Factors contributing to this dissatisfaction include prolonged waiting times for GP and hospital appointments, staffing shortages, and perceived inadequate
government spending.
A full CPE Committee Meeting was organised in London on April 17 and 18, 2024, to discuss crucial sectoral issues.
Key topics discussed during the two-day meeting included intolerable pressures on pharmacy owners, the ongoing Community Pharmacy Contractual Framework (CPCF)
negotiations, implementation of the Pharmacy First service, and governance changes.
Committee Members reviewed the progress of CPCF negotiations with the Department of Health and Social Care (DHSC) and NHS England. These critical negotiations
are being led by the Negotiating Team (NT), which includes independent pharmacy owners and representatives of CCA and non-CCA multiples.
The CPE has been advocating for an uplift to the core global sum, margin write-offs, an agreed mechanism for regular funding increases linked to activity and
inflation, annual uplifts to service fees, more fundamental reform of the margin delivery framework and an economic review of the medicines supply chain.
The Committee also discussed the results of the 2024 Pharmacy Pressures Survey, which was conducted during March and April.
The STADA Health Report 2024, published today, has revealed a significant decline in satisfaction with national healthcare systems across Europe, with a
notable drop seen in the UK, Germany, and Kazakhstan.
According to the report, satisfaction with the UK's healthcare system dropped sharply by 11 percentage points in just one year, falling from 67 percent in 2023
to 56 percent in 2024, likely fuelled by "post-pandemic pressure on the National Health Service (NHS)." In 2020, satisfaction stood at 85 percent before declining
to its current level.
In terms of discontentment over healthcare, Britain is followed closely by Kazakhstan and Germany, where satisfaction fell by 10 and 8 percent respectively in
one year.
The 10th annual health report released by global healthcare leader STADA Arzneimittel AG, the parent company of Thornton & Ross, is based on a survey of over
46,000 respondents aged 18 to 99 across 32 countries, with around 2,000 respondents in each country.
A continuous decline in satisfaction levels has been observed since 2021. Overall satisfaction with healthcare systems in Europe was recorded at 74 percent in
2020, just before the pandemic. This figure dropped to 71 percent in 2021, 64 percent in 2022, and 61 percent in 2023.
With the increasing stress environment infertility has been steadily increasing in Gurgaon. In a recent survey 15 out of every 100 couples in urban India are opting for Alternate Reproductive Procedure (ARP). However choosing the right IVF Specialist can be a daunting task for the couples. Generally it is seen that Gurgaon couples start consulting for gynaecologists in South Delhi as south delhi has better quality of gynae doctors and facility. However it should be kept in mind that IVF is a complex and lengthy process so one should go for experts in IVF and not general gynaecologist and that too in Gurgaon.
https://explorehealthnews.blogspot.com/2017/07/how-to-choose-right-ivf-specialist.html
The full version of the Community Pharmacy Assurance Framework (CPAF) questionnaire is now available for selected pharmacies to complete.
This follows a screening questionnaire in July, which all community pharmacies in England were asked to complete as part of the CPAF process.
Pharmacies may be selected for the full, comprehensive CPAF questionnaire if, for example, they did not complete a screening questionnaire or if there are concerns about the pharmacy relating to patient safety. Some pharmacies may also be selected to validate their screening questionnaire answers.
The NHS Business Services Authority (NHSBSA) said selected pharmacies have been contacted. It's mandatory to complete the survey which can be used as a training tool and for continuous monitoring of compliance against the community pharmacy contract.
Lack of staffing and increased demand from patients is mounting unsustainable pressure on the NHS, putting patient safety and care at risk, a new poll of NHS
leaders by the NHS Confederation revealed.
NHS leaders in England warned that the service has reached a "tipping point" with nearly 88 per cent saying "the demands on their organisation are unsustainable."
The survey, published ahead of the monthly performance figures for the NHS England, covered leaders across hospitals, ambulance services, mental health providers, community services, primary care and integrated care systems.
It highlighted primary care, urgent and emergency care as greatest areas of concern, with record levels of demand on A&E departments and increasing bed occupancy
rates.
Researchers have projected the rates of liver disease and associated deaths due to increased alcohol consumption during the Covid-19 pandemic.
The research has been published in the 'Hepatology Journal'.
A team led by investigators at Massachusetts General Hospital used data from a national survey of US adults on their drinking habits that found that excessive drinking (such as binge drinking) increased by 21 per cent during the Covid-19 pandemic.
The scientists simulated the drinking trajectories and liver disease trends in all US adults.
They estimated that a one-year increase in alcohol consumption during the Covid-19 pandemic will result in 8,000 additional deaths from alcohol-related liver disease, 18,700 cases of liver failure, and 1,000 cases of liver cancer by 2040. In the short term, alcohol consumption changes due to Covid-19 are expected to cause 100 additional deaths and 2,800 additional cases of liver failure by 2023.
The researchers noted that a sustained increase in alcohol consumption for more than one year could result in 19-35 per cent additional mortality.
As part of its inclusion and diversity strategy, the Royal Pharmaceutical Society (RPS) has launched a campaign to challenge barriers to working in pharmacy for those with disabilities.
A profession-wide survey on the subject conducted by the RPS, identified disability as the biggest barrier to working in pharmacy, highlighting the area of work to support pharmacists.
The campaign will focus on reducing barriers to enter the profession, developing more accessible working environments and encouraging employers to collect data on disability in the workplace.
The campaign, based on inputs from the RPS Ability Group volunteers with visible and non-visible disabilities, will run until the end of March.
Following recommendation of the RPS Ability Group, RPS has written to the General Pharmaceutical Council (GPhC) the Higher Education Occupational Practitioners (HEOPS) to update the guidance on standards of medical fitness for pharmacy students.
Calls have been made for more pharmacies to help with the rollout of the county's coronavirus booster jabs.
Around 25 pharmacies in Kent and Medway have been distributing vaccines to thousands of patients.
This represents just seven per cent of the 320 pharmacies in the county.
The call comes despite staff shortages and growing workload pressures, such as carrying out non-essential tasks, which include patient satisfaction surveys.
Shilpa Shah, the chief executive officer at the Kent Local Pharmaceutical Committee, said: "We have workforce issues, but are pulling together to deliver essential patient services and Covid vaccinations at the same time."
Pharmacies are one of several health organisations working hard to ensure that everyone aged 18 and over will be offered a booster vaccination by the target of January 31, which has been set by the government.
The prevalence of Covid-19 infections in England rose to around one in 60 people in the week ending November 27, the Office for National Statistics said today (December 03), led higher by the dominant Delta variant rather than the newly identified Omicron.
The prevalence was up from one in 65 reported the previous week, the ONS said, adding that 99 per cent of all coronavirus infections which were sequenced were
genetically compatible with the Delta variant.
"To date, we have not identified any infections compatible with the new Omicron variant (B.1.1.529) among our survey participants," the ONS said.
Prime Minister Boris Johnson has introduced travel restrictions and some mask mandates, with a view to slowing the spread of Omicron while work is undertaken to
understand it better.
There have been 42 confirmed cases of the variant in Britain, which has mutations consistent with reduced vaccine efficacy.
The Chief Pharmacist for England and Co-Chairs of professional leadership commission has responded to the questions raised by the Pharmacists Defence Association
(PDA)'s member on the professional leadership survey.
In early September, the PDA wrote to the UK's Chief Pharmaceutical Officers to increase transparency and confidence in the process by asking for clarification of
some of the commission's thinking, assumptions, and scope.
On behalf of all four CPhOs, Chief Pharmacist for England David Webb provided feedback: "The Commission has two independent co-chairs and members have agreed to
abide by the 7 principles for the conduct of public life as recommended by the Nolan Commission which form part of the Terms of Reference. Commission members have
been appointed on behalf of all pharmacy professionals to contribute their expertise in and knowledge of professional leadership and are not appointed to represent
their particular countries, organisations, sectors or roles."
The Pharmaceutical Services Negotiating Committee (PSNC) has announced the margin delivery rates will increase from October as the agreed £100m write off is
implemented.
"The baseline margin allowance will remain £800m per year in 2022/23 and 2023/24," said PSNC.
"Margin levels in the last two full years (2020/21 and 2021/22), as measured by the Margin Survey of independent pharmacies, were in excess of the baseline allowance,
meaning that an excess was accrued."
As new services have been introduced and take up of these has accelerated, the amount of unallocated funding left in the CPCF is now less than it previously was.
As such, the value of the Transitional Payments will decrease from its current level. Some of the unallocated funding remaining in 2023/24 will be repurposed into
a Flat Payment for all contractors (see details below).
Over the course of the second half of 2022/23, the value of the Transitional Payments will be phased down. This will start in October 2022 with a reduction in payment
levels to approximately 85% of the current level, as shown in the following table:
The Royal Pharmaceutical Society (RPS) brought together a wide range of pharmacists, pharmacy technicians and pharmacy organisations from across Scotland at
the Scottish Parliament on Monday (3 October) to support people living with disabilities.
The meeting was chaired by Jeremy Balfour MSP, Convener of the Scottish Parliament's Cross-Party Group on Disability, and the meeting was also attended by the Chief
Pharmaceutical Officer Alison Strath.
Attendees of the meeting committed to bold actions to support people living with seen and unseen disabilities to work in pharmacy.
Last year, a survey of RPS members identified that living with a disability was considered to be the biggest barrier to working in pharmacy.
This year, RPS is running a disability in pharmacy awareness campaign, to highlight some of the barriers and challenges raised by RPS members and to work with
stakeholders across pharmacy to overcome these. Yesterday's conversation at the Scottish Parliament was a significant step in achieving this.
There has been extensive national media coverage today (August 11) on how medicine shortages have forced patients to visit multiple pharmacies to get their
prescriptions filled or return to their GP to be prescribed alternative drugs.
These media reports have been based on a survey involving more than 1,500 pharmacists in the UK, in which over a half of those polled said that their patients'
health had been put at risk in the last six months.
In response to a query from Pharmacy Business, the Department of Health and Social Care (DHSC) said it monitors the medicines supply chain closely to prevent any
shortages and acts swiftly when any issue arises.
A DHSC spokesperson told Pharmacy Business: "We take patient safety extremely seriously and we routinely share information about medicine supply issues directly
with the NHS so they can put plans in place to reduce the risk of any shortage impacting patients, including offering alternative medication.
Viveca Biomed has launched an innovative and clinically-proven bladder support device that offers women immediate relief from stress urinary incontinence (SUI)
and provides community pharmacy contractors with a way to build a new consumer base, customer loyalty and sales margins.
The product, named 'Contrelle Activgard', has already recorded millions of sales in Scandinavia over a decade.
The company behind the UK launch is female healthcare business Viveca Biomed, founded in 2019 by Andrew Tasker who has spent 30+ years in senior roles within the OTC
and pharma industry.
Contrelle is manufactured, packed and distributed in the UK at Viveca Biomed's factory near Newcastle, with no outsourcing, and thus offering the best possible
continuity of supply.
Ahead of the launch, the company commissioned a large consumer lifestyle survey with 500 women over 40 years of age who experience bladder leaks, to reveal the extent
of its detrimental impact.
Contrelle Activgard is a safe, discrete, easy-to-use and highly effective, single-use vaginal device, designed to immediately prevent SUI rather than just deal
with the leakage.
The Royal Pharmaceutical Society (RPS) Director for Scotland Clare Morrison participated in the panel discussion alongside representatives from other health
professional organisations on tackling the workforce crisis at the SNP conference in Aberdeen on 8 October.
At the conference, the Cabinet Secretary for Health and Social Care committed to achieving protected learning time for health professionals. Morrison welcomed the
Cabinet Secretary's statement as fantastic news for pharmacists across Scotland.
"RPS Scotland will follow up the discussion by writing to the Cabinet Secretary to request a meeting to discuss achieving protected learning time, the forthcoming
results of our workforce wellbeing survey, and positive examples of how pharmacy teams have improved the well-being of their teams," said the society.
The NHS Business Services Authority (NHSBSA) has published the Drug Tariff Category M price list for July which reflects an increase in reimbursement
level of approximately £5m per quarter.
An adjustment of -£23.8m was announced, in light of the results of the margin survey (latest result up until end of December 2022), and the phasing down of the
additional £100m agreed across years 4 and 5 as part of the Community Pharmacy Contractual Framework and uplifts for underlying market prices
(between January - March 2023).
Community Pharmacy England has agreed the adjustments based on the analysis of margin delivery and on current projections for 2023/24.
It said: "The objectives are to ensure full delivery of agreed margin and smooth delivery as much as possible. As always, the impact on individual pharmacies
will vary depending on dispensing mix."
Community pharmacies are located within the very hotspots of peoples' communities, yet a staggering 720 individual businesses have stopped trading since 2015.
It has been called a "national disgrace and a betrayal to the elderly and the vulnerable" by sector leaders.
The funding crisis has been compounded by a gruelling 18-24 months post-Covid, both have which have placed immense pressure on the retail pharmacy sector.
The population is aging and with this comes patients living with a range of long-term health conditions. Medication regimes are becoming ever more complex and as a
result, maintaining prescription and medication adherence services is challenging to say the least.
Yet the public feel great warmth towards their local pharmacy businesses, and this positive attitude only increased during the pandemic. In fact, in a recent report
launched by Omnicell on the Changing Role of the Pharmacist, a survey of public opinion found that a third (32 per cent) said they perception of their local
pharmacy had changed for the better since the start of the pandemic and nearly half (44 per cent) said they are more familiar with their local pharmacy services
since the start of COVID.
This has meant that the role of the pharmacist has also changed and evolved; in part due to a national need and drive for more patients to be seen and supported
clinically by pharmacists.
This change of service provider role has slowly been developing over the last couple of years. Pharmacists are currently carrying out 65 million consultations
a year - a staggering rise of 44 per cent in the last 24 months alone.
The Pharmacists Defence Association (PDA) has expressed its keenness to work with the NHS nationally and at the ICB level to discuss how the pharmacist
workforce can most effectively be part of the multidisciplinary team, after the publication of Long-awaited NHS England workforce plan.
Welcoming its publication Alison Jones, PDA Director of Policy said: "It gives greater clarity around the future direction and strategy for professional development,
training, and opportunities for those currently working in the health service or considering their future career. There is a strong emphasis on further development
of the clinical role of pharmacists to support better patient care.
"However, this is a plan that will take years, indeed decades to come to fruition and its success will need to be underpinned by significant funding for its entire
life course.
Workplace pressures, reductions in support staff, and a lack of protected learning time are matters of immediate concern for many PDA members, issues which are
regularly highlighted through activities, such as the safer pharmacies survey.